50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]

RxCUI
1091167
RxNorm name
50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]
Display name
50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]
Full name
50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
effd952d-ac94-47bb-b107-589a4934dccaRitalin LA 20 MG 24HR Extended Release Oral Capsule [PSN] · 50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin] [SBD] · Ritalin LA 20 MG 24 HR Extended Release Oral Capsule [SY]336These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA ® (methylphenidate hydrochloride) extended-release capsules for oral use, CII Initial U.S. Approval: 195520250923